Source: Virtual Congress 2021 – Primary care organisation and epidemiology



Rating:

Share or cite this content

Citations should be made in the following way:
V. Foos (Cardiff, United Kingdom), P. Mcewan (Cardiff, United Kingdom), U. Holmgren (Gothenburg, Sweden), J. Marshall (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), E. De Nigris (Cambridge, United Kingdom). Projections of 10-year mortality in patients with COPD in the UK using the CHOPIN policy model. 1012

Member's Comments

No comment yet.

Related content which might interest you: Risk charts of five-year mortality in COPD patients Source: International Congress 2019 – COPD: epidemiology and spirometry Year: 2019 Ten-year projected outcomes associated with increased use of triple therapies in UK patients with COPD using the COPD Health Outcome Policy and INtervention (CHOPIN) model Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data Year: 2021 Cause-specific mortality rates in patients with COPD in primary care: a prospective analysis of the Birmingham COPD Cohort Study Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care Year: 2020 Predicting 12-month mortality in a Scottish COPD cohort Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Predictive value of annual costs on 3-year mortality in COPD Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes Year: 2015 Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021 Trends in COPD mortality – Tales from the Swedish mortality register Source: Eur Respir J 2003; 22: Suppl. 45, 485s Year: 2003 Corerelation of COPD exacerbation with comorbidities, Lung function and mortality within a single-practice primary-care cohort in the UK Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Four-year follow up of a COPD cohort, participation and mortality Source: Annual Congress 2009 - Exacerbations and characteristics of COPD Year: 2009 COPD phenotypes and 5-years mortality risk prediction: PALOMB Cohort Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020 Predictors of long-term mortality after hospitalization for COPD; A Scandinavian multicentre study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Excess economic burden of comorbidities in COPD: a 15-year population-based study Source: Eur Respir J, 50 (1) 1700393; 10.1183/13993003.00393-2017 Year: 2017 Trends and predictors of asthma costs: results from a 10-year longitudinal study Source: Eur Respir J 2016; 47: 801-809 Year: 2016 Risk factors for COPD mortality in women in the UK Source: Eur Respir J 2006; 28: Suppl. 50, 463s Year: 2006 Two year mortality of COPD in primary care in Greece: An observational study Source: Annual Congress 2011 - Quality of diagnosis and assessment in primary care Year: 2011 International trends in COPD mortality, 1995–2017 Source: Eur Respir J, 54 (6) 1901791; 10.1183/13993003.01791-2019 Year: 2019 Pharmacological management and risk of mortality after first COPD hospitalization (HERA) Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Multinational, database cohort study to study mortality and risk factors of mortality in patients with asthma Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality Year: 2016 Disease activity in long-term survivors of COPD: 10-years’ follow-up data from the Hokkaido COPD cohort study Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Global and regional trends in COPD mortality, 1990–2010 Source: Eur Respir J 2015; 45: 1239-1247 Year: 2015